Aveanna Healthcare Holdings Inc. (AVAH) P/E Ratio History
UndervaluedTrading at 12.0x vs 5Y avg 74.1x · 43th percentile · Below historical baseline · Data 2021–2026
Loading P/E history...
P/E Ratio Analysis
As of October 3, 2026, Aveanna Healthcare Holdings Inc. (AVAH) trades at a price-to-earnings ratio of 12.0x, with a stock price of $12.59 and trailing twelve-month earnings per share of $1.22.
The current P/E is 84% below its 5-year average of 74.1x. Over the past five years, AVAH's P/E has ranged from a low of 5.3x to a high of 339.9x, placing the current valuation at the 43th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.2x, AVAH trades at a 48% discount to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 190.0x.
Relative to the broader market, AVAH trades at a notable discount to the S&P 500 median P/E of 24.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AVAH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AVAH Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
AVAH P/E vs Peers
Home-based care services peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 46.7 | 4.64 | +18% | |
| $2B | 21.4 | 1.06 | +23% | |
| $1B | 25.8 | - | +53%Best | |
| $10B | 29.4 | 2.13 | +14% | |
| $3B | 9.6Lowest | 0.94 | +10% | |
| $4B | 17.8 | - | +3% | |
| $3B | 19.1 | 0.39Best | +40% | |
| $338B | 28.1 | - | -15% | |
| $110B | 62.2 | - | -62% | |
| $47B | 39.5 | - | -1% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
AVAH Historical P/E Data (2021–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | Jul 04 2026 | $9.10 | $1.26 | 7.2x | -90% |
| FY2026 Q1 | Apr 04 2026 | $6.38 | $1.21 | 5.3x | -93% |
| FY2025 Q4 | Jan 03 2026 | $8.08 | $1.05 | 7.7x | -90% |
| FY2025 Q3 | Sep 27 2025 | $8.75 | $0.36 | 24.4x | -67% |
| FY2025 Q2 | Jun 28 2025 | $5.02 | $0.08 | 66.8x | -10% |
| FY2025 Q1 | Mar 29 2025 | $5.37 | $0.02 | 339.9x | +358% |
| FY2021 Q2 | Jul 03 2021 | $12.47 | $0.18 | 67.8x | -9% |
Average P/E for displayed period: 74.1x
AVAH Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AVAH — Frequently Asked Questions
Quick answers to the most common questions about buying AVAH stock.
What is AVAH's P/E ratio?
Aveanna Healthcare Holdings Inc. (AVAH) trailing twelve-month P/E ratio is 12.0x, based on TTM diluted EPS of $1.22. The 5-year average P/E is 74.1x and the historical range spans 5.3x to 339.9x.
Is AVAH stock overvalued or undervalued?
AVAH trades at 12.0x P/E, below its 5-year average of 74.1x. At the 43th percentile of its historical range (5.3x–339.9x), the stock is priced at a discount to its own history.
Is AVAH stock expensive?
No, AVAH is not expensive on a historical basis. The current P/E of 12.0x is below the 5-year average of 74.1x and sits at the 43th percentile of its valuation range.
What is AVAH's historical P/E range?
Over the past 5 years, AVAH's P/E ratio has ranged from 5.3x to 339.9x, with a median of 24.4x and an average of 74.1x. The current P/E of 12.0x places the stock at the 43th percentile of this range. Full historical data spans 2021–2026.
How does AVAH's P/E compare to the S&P 500?
AVAH trades at 12.0x P/E versus the S&P 500 median of 24.5x. The 51% discount to the market suggests lower growth expectations or perceived higher risk.
How does AVAH's valuation compare to Healthcare peers?
Aveanna Healthcare Holdings Inc. P/E of 12.0x compares to the Healthcare sector median of 23.2x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is AVAH's PEG ratio?
AVAH PEG ratio is N/A, based on a P/E of 12.0x and EPS growth of 1951.9%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is AVAH's earnings yield?
AVAH earnings yield is 8.34%, the inverse of its 12.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.